• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 13Evidence profile of comparisons of targeted immune modulators for adverse events in children

Number of studies/patientsDesignQualityConsistencyDirectnessMagnitude of effectOther modifying factorsOverall grade of the evidence
All comparisons
Outcome: Adverse events
No direct evidence

From: Appendix I, Evidence profiles

Cover of Drug Class Review: Targeted Immune Modulators
Drug Class Review: Targeted Immune Modulators: Final Update 3 Report [Internet].
Thaler KJ, Gartlehner G, Kien C, et al.
Portland (OR): Oregon Health & Science University; 2012 Mar.
Copyright © 2012, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.